Evidence map›Paper›PMID 32840805›Full record

ArticleInternal and emergency medicine2020

Prevalence of asymptomatic deep vein thrombosis in patients hospitalized with SARS-CoV-2 pneumonia: a cross-sectional study.

Matteo Giorgi-Pierfranceschi, Oriana Paoletti, Angelo Pan, Fabio De Gennaro, Anna Laura Nardecchia, Rossella Morandini, Claudia Dellanoce, Samuele Lombi, Maurizio Tala, Vanessa Cancelli and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Internal and emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Screening for venous thromboembolism in patients with COVID-19.Journal of thrombosis and thrombolysis · 2021
    Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Matteo Giorgi-PierfranceschiDepartment of Internal Medicine, Hospital of Cremona, Viale Concordia 1, 26100, Cremona, Italy. magiopi65@gmail.com.ORCID http://orcid.org/0000-0002-7988-9652
Oriana PaolettiHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Angelo PanDepartment of Infectious Disease, Hospital of Cremona, Cremona, Italy.
Fabio De GennaroDepartment of Internal Medicine, Hospital of Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Anna Laura NardecchiaDepartment of Internal Medicine, Hospital of Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Rossella MorandiniHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Claudia DellanoceHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Samuele LombiDepartment of Internal Medicine, Hospital of Cremona, Viale Concordia 1, 26100, Cremona, Italy.
Maurizio TalaHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Vanessa CancelliHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Silvia ZambelliHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Giancarlo BosioDepartment of Pneumology, Hospital of Cremona, Cremona, Italy.
Laura RomaniniDepartment of Radiology, Hospital of Cremona, Cremona, Italy.
Sophie TestaHaemostasis and Thrombosis Center, Hospital of Cremona, Cremona, Italy.
Istituti Ospitalieri di Cremona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association between coronavirus disease 2019 (COVID-19) pneumonia and venous thrombotic disorders is still unclear. We assessed the association between COVID-19 infection-related pneumonia and proximal deep-vein thrombosis (DVT) in a cohort of patients admitted to our hospital during the European outbreak in the front line of Cremona, Lombardy. In a single-center cross-sectional study, all patients hospitalized for more than 5 days in Internal Medicine Department with confirmed COVID-19 pneumonia received 2-point compressive ultrasound assessment (CUS) of the leg vein system during a single day. Ninety-four percent of patients received enoxaparin as standard pharmacological prophylaxis for venous thromboembolism. The presence of DVT was defined as incompressibility of popliteal or common femoral vein. Out of 121 patients with COVID-19 pneumonia (mean age 71.8, 66.3% males) hospitalized on March 31st, 70 stayed in hospital for over 5 days and 66 of them underwent CUS of deep venous system of the legs. The presence of asymptomatic DVT was found in 9 patients (13.6%). No symptomatic DVT was found. Patients with DVT showed mean age = 75.7 years, mean D-dimer levels = 4.02 ng/ml and all of them received enoxaparin for thromboprophylaxis, except one. Computed tomography pulmonary angiogram confirmed pulmonary embolism in five patients. One every seven patients with COVID-19-related pneumonia, hospitalized for more than 5 days, had asymptomatic proximal DVT and half of them had confirmed PE despite standard pharmacological thromboprophylaxis. This observational study suggests the need of an active surveillance through CUS in patients hospitalized with acute SARS-COV-2 and underline the need of a more intense thromboprophylaxis.

Indexed as

AgedAged, 80 and overAsymptomatic DiseasesCoronavirus InfectionsCOVID-19Cross-Sectional StudiesFemaleHumansItalyMaleMiddle AgedPandemicsPneumoniaPneumonia, ViralPrevalenceTomography, X-Ray ComputedAsymptomatic deep veins thrombosisCovid-19 pneumoniaPoint of care ultrasonographyPrevalence

Identifiers

PMID32840805
PMCPMC7445816
OpenAlexW3081054558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.